Advanced Oncotherapy plc (LON:AVO – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1.75 ($0.02) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares trading hands.
Advanced Oncotherapy Price Performance
The firm has a fifty day simple moving average of GBX 1.75 and a 200-day simple moving average of GBX 1.75. The company has a market capitalization of £9.50 million, a PE ratio of -25.00 and a beta of 0.06. The company has a debt-to-equity ratio of 98.71, a quick ratio of 0.13 and a current ratio of 1.26.
About Advanced Oncotherapy
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
Read More
- Five stocks we like better than Advanced Oncotherapy
- What is the Nikkei 225 index?
- California Resources Stock Could Be a Huge Long-Term Winner
- What Do S&P 500 Stocks Tell Investors About the Market?
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- Using the MarketBeat Dividend Tax Calculator
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.
